YU102103A - Mycoplasma bovis vakcina i postupci redukovanja pneumonije kod životinja - Google Patents
Mycoplasma bovis vakcina i postupci redukovanja pneumonije kod životinjaInfo
- Publication number
- YU102103A YU102103A YU102103A YUP102103A YU102103A YU 102103 A YU102103 A YU 102103A YU 102103 A YU102103 A YU 102103A YU P102103 A YUP102103 A YU P102103A YU 102103 A YU102103 A YU 102103A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- mycoplasma bovis
- vaccine
- methods
- animals
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Ovaj pronalazak se odnosi na Mycoplasma bovis vakcine i postupke za tretiranje ili prevenciju bolesti ili poremećaja kod životinja koji su izazvani infekcijom sa Mycoplasma bovis putem ordiniranja životinja efikasne količine Mycoplasma bovis vakcine. Mycoplasma bovis vakcina može biti cela ili parcijalna inaktivisana ćelija ili modifikovani živi preparat, sub-jedinica vakcine, ili nukleinska kiselina ili DNK vakcina. Mycoplasma bovis vakcina koja se ordinira prema ovome može se sintetizovati ili dobiti rekombinovanjem. Ovaj pronalazak se takođe odnosi na kombinovane vakcine, postupke za dobijnje Mycoplasma bovis vakcine i kompleta.[The present invention relates to Mycoplasma bovis vaccines and methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis by administering to the animal an effective amount of a Mycoplasma bovis vaccine. The Mycoplasma bovis vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The Mycoplasma bovis vaccine administered in accordance with the present can be synthesized or recombinantly produced. The invention also related to combination vaccines, methods of preparing Mycoplasma bovis vaccines and kits.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU102103A true YU102103A (sh) | 2006-05-25 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU102103A YU102103A (sh) | 2001-07-02 | 2002-06-27 | Mycoplasma bovis vakcina i postupci redukovanja pneumonije kod životinja |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (sh) |
| EP (1) | EP1401488A1 (sh) |
| JP (1) | JP2004536106A (sh) |
| KR (1) | KR20040030783A (sh) |
| CN (1) | CN1522152A (sh) |
| AP (1) | AP2002002568A0 (sh) |
| AR (1) | AR036125A1 (sh) |
| BG (1) | BG108496A (sh) |
| BR (1) | BR0210798A (sh) |
| CA (1) | CA2452580A1 (sh) |
| CZ (1) | CZ20033465A3 (sh) |
| EA (1) | EA200301324A1 (sh) |
| GT (1) | GT200200139A (sh) |
| HN (1) | HN2002000162A (sh) |
| HR (1) | HRP20031078A2 (sh) |
| HU (1) | HUP0501188A2 (sh) |
| IL (1) | IL159516A0 (sh) |
| IS (1) | IS7078A (sh) |
| MA (1) | MA27048A1 (sh) |
| MX (1) | MXPA03011815A (sh) |
| NO (1) | NO20035767L (sh) |
| OA (1) | OA12640A (sh) |
| PA (1) | PA8549801A1 (sh) |
| PE (1) | PE20030239A1 (sh) |
| PL (1) | PL373891A1 (sh) |
| SK (1) | SK15802003A3 (sh) |
| TN (1) | TNSN03154A1 (sh) |
| UY (1) | UY27365A1 (sh) |
| WO (1) | WO2003004052A1 (sh) |
| YU (1) | YU102103A (sh) |
| ZA (1) | ZA200309747B (sh) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| EP2121721A4 (en) * | 2006-09-07 | 2010-10-06 | Boehringer Ingelheim Vetmed | GENOTYPING BASED ON PCR |
| WO2008032158A2 (en) | 2006-09-11 | 2008-03-20 | Pfizer Products Inc. | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| AR069087A1 (es) * | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| US8586059B2 (en) * | 2008-07-03 | 2013-11-19 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
| KR20110089260A (ko) * | 2008-10-31 | 2011-08-05 | 베링거잉겔하임베트메디카인코퍼레이티드 | 다가 백신 조성물에서 마이코플라즈마 보비스 유래의 항원을 포함하는 다양한 항원의 용도 |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| TWI583403B (zh) | 2009-06-04 | 2017-05-21 | 國立感染症研究所 | 黴漿菌感染症用疫苗 |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| CN108379571A (zh) | 2012-12-28 | 2018-08-10 | 勃林格殷格翰动物保健有限公司 | 支原体疫苗的制备方法 |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| CN115141773A (zh) | 2015-08-14 | 2022-10-04 | 硕腾服务有限责任公司 | 牛支原体组合物 |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| JP2003513935A (ja) * | 1999-11-08 | 2003-04-15 | バイオミューン | マイコプラズマ・ボビスに対するワクチンおよび使用方法 |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Application Discontinuation
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Application Discontinuation
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-23 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2002002568A0 (en) | 2002-06-30 |
| EP1401488A1 (en) | 2004-03-31 |
| PL373891A1 (en) | 2005-09-19 |
| CA2452580A1 (en) | 2003-01-16 |
| SK15802003A3 (sk) | 2005-01-03 |
| UY27365A1 (es) | 2003-04-30 |
| HN2002000162A (es) | 2002-09-17 |
| CN1522152A (zh) | 2004-08-18 |
| NO20035767L (no) | 2004-01-30 |
| AR036125A1 (es) | 2004-08-11 |
| PA8549801A1 (es) | 2003-09-17 |
| US20030147914A1 (en) | 2003-08-07 |
| OA12640A (en) | 2006-06-15 |
| TNSN03154A1 (fr) | 2005-12-23 |
| WO2003004052A1 (en) | 2003-01-16 |
| EA200301324A1 (ru) | 2004-12-30 |
| MXPA03011815A (es) | 2004-04-02 |
| CZ20033465A3 (cs) | 2004-12-15 |
| GT200200139A (es) | 2003-02-13 |
| IS7078A (is) | 2003-12-15 |
| PE20030239A1 (es) | 2003-03-21 |
| JP2004536106A (ja) | 2004-12-02 |
| ZA200309747B (en) | 2005-05-27 |
| BG108496A (en) | 2005-02-28 |
| MA27048A1 (fr) | 2004-12-20 |
| HUP0501188A2 (en) | 2006-05-29 |
| IL159516A0 (en) | 2004-06-01 |
| BR0210798A (pt) | 2006-05-23 |
| HRP20031078A2 (en) | 2005-08-31 |
| KR20040030783A (ko) | 2004-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU102103A (sh) | Mycoplasma bovis vakcina i postupci redukovanja pneumonije kod životinja | |
| MXPA03011924A (es) | Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. | |
| YU102203A (sh) | Vakcinacija sa jednokratnom dozom mycoplasma hyopneumoniae | |
| BR0010612A (pt) | Vacinas | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| ATE461709T1 (de) | Choline-bindende proteine derivate aus pneumokoken als impfstoff | |
| MY128159A (en) | Methods and composition for oral vaccination | |
| RU2005128790A (ru) | Модифицированные живые вакцины, содержащие вирус бычьего герпеса типа 1 (bhv-1(ibr)) и/или вирус бычьей вирусной диареи (bvdv), для беременных и вскармливаемых особей скота | |
| MXPA04001872A (es) | Modelo de exposicion a micoplasma bovis, procedimiento para administrar m. bovis y procedimientos para inducir lesiones pulmonares neumonicas. | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
| DE602005011041D1 (de) | Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| CY1116862T1 (el) | Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae | |
| FR2804026B1 (fr) | Vaccination contre l'herpesvirose canine et vaccins | |
| MY168662A (en) | Attenuated bacteria for use in a vaccine | |
| MY188912A (en) | Attenuated bacteria for use in a vaccine | |
| MY177164A (en) | Attenuated bacteria for use in a vaccine | |
| MY177159A (en) | Attenuated bacteria for use in a vaccine | |
| TH75687A (th) | วัคซีนไวรัสโรคโลหิตจางในไก่จากเซลล์ไลน์ | |
| UA12940U (en) | Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals |